Source: Billy |NwoReport
The Food and Drug Administration announced Thursday it is limiting the use of the Johnson & Johnson one-shot COVID-19 vaccine after an investigation revealed that those who got the jab were at increased risk of developing life-threatening blood clots.
It is now only authorizing the brand’s COVID vaccine to people 18 or older for whom other authorized or approved vaccines are not accessible or clinically appropriate, and to those 18 years or older who otherwise would not get a COVID vaccine.
The decision comes following an investigation into reports of thrombosis and thrombocytopenia syndrome – a rare and potentially life-threatening syndrome that creates blood clots and creates low levels of blood platelets – from those who have received the vaccine.
Symptoms began in those cases about one to two weeks after the individual received the vaccine.